Healius Ltd - Company Profile
Powered by 
All the sales intelligence you need on Healius Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Healius Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Healius Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Healius Ltd (Healius), formerly Primary Health Care Ltd, is a healthcare company that offers a range of medical and health-related services and healthcare technology solutions to medical and allied health professionals. Its major services include anatomical pathology, clinical pathology, IVF centers, genomic diagnostics, day hospitals and veterinary pathology. The company also offers para-medical, medical and related services, and functions as a daycare surgery operator. It offers healthcare technology solutions to medical practitioners, medical practices and hospitals. The company markets its products under the brand names abbott, agilex biolabs, dorevitch, gatrolab, genomic diagnostics, iq pathology, kossard, laverty, qml, tml, vetnostics, western diagnostic pathology. The company operates medical and pathology centers in Australia and Montserrat with operations in all states and territories. Healius is headquartered in Sydney, New South Wales, Australia.
Headquarters
Australia
Address
Level 22, Liberty Place, 161 Castlereagh Street, Sydney, New South Wales, 2000
Website
www.healius.com.au
Telephone
61 2 94329400
No of Employees
8,000
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
HLS (ASX)
Revenue (2025)
$886.7M
5.7%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
76.6%
(2025 vs 2024)
Market Cap*
$258.9M
Net Profit Margin (2025)
XYZ
77.9%
(2025 vs 2024)
* As of and is in US$
Healius Ltd premium industry data and analytics
Products and Services
| Services |
|---|
| Diagnostic Imaging Services |
| General X-ray |
| Fluoroscopic Screening |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In December, the company entered into a contract with the Australian Department of Defense to deliver private pathology services to the Australian Defense Force. |
| 2025 | Divestiture | In May, the company sold Lumus Imaging to Affinity Equity Partners (Australia) Pty Limited. |
| 2024 | New Products/Services | In July, the company's Imaging division, Lumus Imaging introduced new AI technology for the screening of tuberculosis (TB). |
Competitor Comparison
| Key Parameters | Healius Ltd | Ramsay Health Care Ltd | Sonic Healthcare Ltd | Healthscope Ltd |
|---|---|---|---|---|
| Headquarters | Australia | Australia | Australia | Australia |
| City | Sydney | Sydney | Sydney | Melbourne |
| State/Province | New South Wales | New South Wales | New South Wales | Victoria |
| No. of Employees | 8,000 | 90,000 | 45,000 | 19,000 |
| Entity Type | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Paul Anderson | Chief Executive Officer; Managing Director | Executive Board | 2024 | - |
| Andrew Thomson | Chief Financial Officer | Senior Management | 2025 | - |
| Puneet Nagi | Chief Operating Officer | Senior Management | 2025 | - |
| Arjun Narang | Group Executive, Operations Transformation | Senior Management | - | - |
| Mark Neeham | Group Executive - Government & External Affairs | Senior Management | 2015 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer